RxDoctor Payments Data

Craig Turner, MD

Family Medicine · Monroe, LANPI 1598738049

Payments from drug & device makers

$407in general payments, 2019–2025

Across 15 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$129
  • Acadia Pharmaceuticals Inc$94
  • Johnson & Johnson$62
  • Neurocrine Biosciences, Inc.$42
  • Novartis$32
  • Inogen, Inc.$18
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$33582%
  • Education$7118%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$407 in reported general payments places this provider in the 40th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$139,240
Medicare patients
331
Services billed
1,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban366$105,366
LinzessLinaclotide72$39,883
RexultiBrexpiprazole39$28,262
JardianceEmpagliflozin69$21,189
MyrbetriqMirabegron84$18,842
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$18,752
EntrestoSacubitril/Valsartan49$13,673
Rivastigmine79$13,215
JanuviaSitagliptin Phosphate44$12,822
Potassium Chloride284$7,737
Pantoprazole Sodium398$7,182
Budesonide18$7,102
Atorvastatin Calcium469$6,078
Memantine Hcl174$5,802
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc54$5,510

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Restasis, Creon$14$49,07299 claims
NovartisEntresto$32$13,67349 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →